CYTK Exercise Disclosure
Malik Fady Ibraham · SEC Form 4 · Filed Sep 8, 2026
Exercise
Calculated transaction value
$0
Malik Fady Ibraham EVP Research & Development
CYTK
Cytokinetics Inc
CYTK
Transaction date
Sep 8, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed same day
CYTK daily price context
Close on/before transaction
$75.35
Sep 8, 2026
Close before public filing
$72.72
Sep 7, 2026
Return since public filing
+1.44%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 3,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001061983-26-000092
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$291.41K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Cytokinetics Inc CYTK | Exercise | Sep 8, 2026 | $27.3K |
| Cytokinetics Inc CYTK | Sale | Sep 8, 2026 | $264.11K |
| Cytokinetics Inc CYTK Current | Exercise | Sep 8, 2026 | $0 |